跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,973 条关于
“Gem-miR-129”
全部
16,973
临床试验
13,745
药物
1,582
机构
160
资讯
1,486
上个月
Novel miRNA-129–Based Therapy Achieves Over 95% Tumor Shrinkage in Preclinical NSCLC Model, Halting Drug Resistance
2个月前
GEM Commits Up to NT$500 Million to Senhwa Biosciences to Advance Oncology Pipeline
去年
CSF Biomarkers NfL, CHIT1, and miR-181b Evaluated for ALS Diagnosis and Prognosis
去年
Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease
去年
Hinge Bio Secures $30 Million to Advance GEM-DIMER Platform for Autoimmune Therapies
去年
Astellas Commits €129 Million to Expand Irish Operations with Focus on Biologics Manufacturing
去年
Technology-Assisted Health Coaching Fails to Achieve Significant Weight Loss in Primary Care Trial
去年
Singapore's EBC-129 Antibody-Drug Conjugate Receives FDA Fast Track Designation for Pancreatic Cancer Treatment
28天前
Australian researchers uncover molecular switch driving triple-negative breast cancer metastasis, pointing to CDK4/6 inhibitor repurposing
去年
HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles
第 1 页,共 149 页
上一页
下一页